🇺🇸 COT in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 10
Most-reported reactions
- Adult Failure To Thrive — 1 report (10%)
- Blood Glucose Abnormal — 1 report (10%)
- Blood Potassium Decreased — 1 report (10%)
- Clostridium Difficile Infection — 1 report (10%)
- Deep Vein Thrombosis — 1 report (10%)
- Device Malfunction — 1 report (10%)
- Dysphagia — 1 report (10%)
- Dyspnoea — 1 report (10%)
- Headache — 1 report (10%)
- Hypoacusis — 1 report (10%)
Other Respiratory approved in United States
Frequently asked questions
Is COT approved in United States?
COT does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for COT in United States?
Evon Medics LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.